|
Cribriform Atypical Ductal Hyperplasia (ADH) |
Low-Grade Ductal Carcinoma In Situ (DCIS) |
Age |
Adult women |
Adult women, usually older than 50 y |
Location |
Anywhere in the breast |
Anywhere in the breast |
Imaging findings |
Calcifications, or incidental finding |
Calcifications, rarely mass-forming |
Etiology |
Unknown |
Unknown |
Histology |
Terminal duct lobular unit contains a uniform proliferation of small, bland cells with distinct cell borders and even cell placement but process incompletely occupies the involved spaces (Figs. 4.1.1, 4.1.2, 4.1.3, 4.1.4, 4.1.5)
Rigid architecture consisting of cribriform spaces or mixed solid and cribriform areas (Figs. 4.1.2, 4.1.3, 4.1.4)
Subtle microrosettes may be present (Fig. 4.1.5)
Limited extent, usually confined to the terminal duct lobular unit and measuring less than 2 mm (Fig. 4.1.1)
|
Terminal duct lobular units, as well as true ducts contain a uniform proliferation of small bland cells (Figs. 4.1.6, 4.1.7, 4.1.8, 4.1.9, 4.1.10)
Complete involvement of at least two adjacent spaces, equivalent to a linear extent of at least 3 mm (Figs. 4.1.6, 4.1.7, 4.1.8)
Cell borders are distinct, and cells are evenly placed (Fig. 4.1.9)
Rigid architecture with cribriform or micropapillary patterns most common (Figs. 4.1.7, 4.1.8, 4.1.9, 4.1.10); solid growth pattern may contain microrosettes
True duct involvement often (Figs. 4.1.6 and 4.1.7)
|
Special studies |
None, CK5/6 usually not expressed |
None; CK5/6 usually not expressed; estrogen receptor (ER) routinely assessed to predict response to adjuvant endocrine therapy; multigene assay may predict which patients may be spared radiation |
Genetic abnormalities |
Loss of 16q, 17p |
Loss of 16q, 17p |
Treatment |
Excision if detected in core biopsy, mammographic follow-up ± antiestrogen therapy |
Complete excision with negative margins, ± adjuvant radiation, ± antiestrogen therapy; sentinel lymph node biopsy not indicated |
Clinical implication |
Moderately increased risk of later cancer development (4-5×); risk is bilateral |
Development of invasive carcinoma in approximately 30% of cases if incompletely excised; with complete excision recurrence rate is approximately 5%-8% without radiation; when limited in extent recurrence rate <5% |